#cannabisaficionado

Industry Innovators

Cheri Sicard: Cannabis Activism Never Tasted So Good

Renowned cannabis chef and activist Cheri Sicard has launched a new website to help eductae people on how to create their own edibles and topicals.

Published

on

Cheri Sicard
PHOTO | Cheri Sicard
Advertisement Back2Grow Advertisement

There’s no such thing as an edible that’s effective for everyone. Cheri Sicard, aka Cannabis Cheri, knows this well — and she’s teaching others how to perfect infusions that work for each individual.

Her at-home recipes and do-it-yourself projects have earned her the title of the “Martha Stewart of Weed“.

But, Sicard wasn’t always a proponent of the plant. In fact, she was “once one of the pot-averse females she’s now aiming to educate,” reports the Daily Beast. 

“Be Involved, Be Educated, Celebrate”

Before she became the acclaimed foodie, activist and entrepreneur she is today, she traveled the world as a variety arts performer in the circus, and as a magician and mentalist. 

“The circus is a traveling melting pot,” says Sicard.

 That’s where she realized her passion for food. In addition to visiting local marketplaces, she says, “I would hang out with a lot of the matriarchs of the families, and I learned how to cook all these ethnic foods.”  

She combined her love for food, and writing — and in 1996, founded FabulousFood.com, one of the largest online recipe sites at the time.

In 2002, Sicard’s first book, The Great American Handbook, was published. The book is described as a guidebook to patriotism, and offers 101 suggestions on how to be involved, educated, and how to celebrate American heritage.

She also authored U.S. Citizenship for Dummies (2003), The Low Carb Restaurant Guide (2004), Everyday American (2008), and The Complete Idiot’s Guide to Easy Freezer Meals (2011), among other books. 

After making a career of teaching others about cuisine, and citizenship — she made the move into the cannabis space where her mantra, “be involved, be educated, celebrate,” still resonates. 

Closeted Smoker to Educated Activist

Cannabis entered Sicard’s life in her late 30s.

“I came late to the party,” she explains. Aside from an occasional toke at a soiree, she says she never really consumed it — not until her doctor recommended it for chronic nausea.

“It worked for that, plus a whole lot of other things,” she says, including gastrointestinal issues, and symptoms of depression.

“It dramatically changed my life,” Sicard adds. 

But, she was raised on Reefer Madness. Despite the positive effects she experienced, Sicard still worried she was harming herself by using cannabis. 

“That’s when I immersed myself in the subject, and I realized I had been taught a lie,” she says. “That really pissed me off.”

Cheri Sicard: Political Junkie on a Mission

What rattled her most was that her earlier work focused on how the U.S. is supposed to work. Once she learned the truth about the Drug War, she says, “I couldn’t shut up about it.”  

Sicard went from being a closed smoker to an outspoken activist. “I haven’t been back since,” she adds.

She turned her anger into activism and began advocating for prisoners currently serving life sentences for cannabis offenses. 

For the most part, the public is unaware that there is such a thing as people who are serving life for pot, Sicard explains. “When I tell people, it’s shocking to them. They think, ‘There’s got to be more involved, there’s got to be dead bodies somewhere.’ But no — it’s just for marijuana.

Sicard works to raise awareness, and rally public support via social media for those serving life for cannabis. 

Whether it’s organizing fundraisers or garnering support for clemency efforts, Sicard’s goal is to “to make sure [the prisoners] know that the public is watching.”

The work is rewarding, Sicard explains, “We’ve seen a lot of victories.” However, there is a long way to go toward righting the wrongs of the Drug War. 

This is where her experience as an entertainer helps serve her in her advocacy work. “The show goes on no matter what,” she explains. “No matter how discouraging it gets, you can’t give up.”

Evolving into a Cannabis Foodie

When cannabis became part of her life, it became part of her food, too.

Naturally, Sicard began to cook with cannabis. Though she was an experienced cook and professional recipe developer — she had to learn the basics of combining the two.

“There wasn’t great information out there at the time. Most of the cookbooks out there weren’t great, and had conflicting information,” she adds. “I had to learn what worked and what didn’t on my own.”

She had her fair share of failures. One of which she describes on her newly launched Cannademy website. 

“[…] When I first started trying to cook with cannabis, there was a great three-day camp-out music festival that a lot of my friends can barely remember. That’s because most of them slept through it.” 

Sicard explains that was due to overestimated tolerances, and her lack of knowledge about making edibles for a crowd.

She learned there’s no one size fits all model for edibles. So, she began to hone-in simple, effective recipes.

That’s when she made her move the world of cannabis and food, becoming a leader in infused recipe development for home chefs. 

In 2012, she self-published The Cannabis Gourmet Cookbook, followed by Mary Jane: The Complete Marijuana Handbook (2015), and most recently, The Easy Cannabis Cookbook (2018).

Her books have gained mainstream attention; Mary Jane is sold at Urban Outfitters, and the Easy Cookbook became the top seller in its category after its release. 

Now, Sicard is taking her skill sets to digital audiences through a series of online courses.

A Pretty Magical Thing

Sicard’s courses focus on the nuances of cooking with cannabis. Topics currently range from skincare to easy cooking for home chefs. She even offers a free course on how to properly dose edibles.

Sicard aims to help consumers who are confused, and inundated with bad information or experiences.

She believes that there’s no such thing as an infused product that works for everyone. This is, in part, why she is focused on teaching others how to create — and properly dose — their own infusions.

Affordability is also a motivation.

Learning how to create your own topicals, for example, can be cost-effective and work just as well or better than products on the market because recipes can be personalized, Sicard explains. 

What sets her courses apart from others is that she directly consults and troubleshoots with her students. 

Because everybody reacts differently, she says, “I really try to focus on where that spot is for them — which can be a pretty magical thing.” 

A personal, and fan-favorite topical recipe is her Lavender Green Tea Whipped Cannabis Body Butter, which is made with Matcha Green Tea powder, beeswax, and hemp seed oil among other ingredients. 

Sicard teaches a free course on how to make the body butter at home with three basic ingredients: coconut oil, cannabis, and tapioca flour or cornstarch. She also offers a tutorial on how to upgrade the recipe with essential oils, extracts, teas and more.  

In terms of dishes, Sicard’s favorites are savory and spicy infusions, like pizza, or barbeque shrimp, she shares. 

She does have a foodie pet peeve; Gummies, or fat-free infusions. 

“Cannabis is better in foods that contain fat,” she explains.

That’s because cannabinoids, like THC and CBD, are fat-soluble, meaning they need fats to dissolve and become bioavailable.

In fact, a recent University of Minnesota study finds that “CBD exposure is vastly increased when CBD is taken with high fatty foods.”

Because of that, Sicard warns consumers to steer clear of fat-free edibles; “Down with fat-free gummies!”  

Sicard credits her success to her brutal honesty. She won’t give you any bullshit, she assures. While she admits that people don’t always like what she tells them, it’s a definite strength in an industry so wrought with misinformation.

Her advice to others is not to be hesitant about cannabis as she was. 

“Get over that. This is something that is good for you. It’s healthy and has long term preventive health benefits.”

Cannabis should be celebrated, not treated as a vice, she says. 

Industry Innovators

Auxly’s Cannabis Sales Rise as Last Year’s One-Time Gain Complicates the Profit Comparison

The Canadian cannabis producer’s revenue and operating cash figures improved, while its headline net-income comparison tells a different story.

Published

on

An aisle between warehouse racks filled with cardboard boxes

Auxly’s third-quarter cannabis results offer two headlines that need to be read together. Net revenue increased 24 percent from a year earlier to C$49.5 million, while reported net income declined. The difference does not mean the sales growth disappeared; it reflects, in part, a comparison with a prior-year quarter containing a substantial one-time gain.

The Canadian cannabis producer released its results November 12, 2026 for the three months ended September 30. Its accompanying financial statements and management discussion are dated November 11. Amounts here are Canadian dollars, avoiding a misleading comparison with U.S.-dollar figures reported by other cannabis companies.

Sales growth and the profit comparison

Auxly’s news release reports adjusted EBITDA of C$15.8 million, up 29 percent, and net income of C$13.6 million, compared with C$20.5 million a year earlier. Management notes that the 2025 comparison included a C$8.1 million after-tax gain related to the Imperial debenture settlement.

That creates a reason to examine the components of earnings rather than selecting whichever headline looks most dramatic. A settlement gain can raise reported profit without representing repeatable sales of cannabis. Conversely, removing selected items produces a different measure whose definition and reconciliation still need to be understood.

Adjusted EBITDA is not the same as net income, and neither is simply the amount of cash available for expansion. Auxly identifies adjusted EBITDA as a non-GAAP measure and directs readers to its reconciliation. The useful comparison is between consistently defined measures over time, with the excluded items visible.

The financial statements add a cash distinction

The interim statements report C$14.3 million of net cash provided by operating activities during the quarter. That differs from the C$14.8 million figure before working-capital changes highlighted in the announcement. Both can be accurate because they describe different stages of the cash-flow calculation.

Working capital includes movements in items such as receivables and inventory. A measure calculated before those movements helps isolate one aspect of performance, but it cannot answer every question about cash actually generated during the period. The statements provide the bridge between the two numbers.

At September 30, the statements show C$51.4 million in cash and cash equivalents. That is a balance at a particular date. It should not be confused with the quarter’s revenue, its net income or a promise that the entire balance will be spent on new production.

The statements also label the interim figures unaudited and explain that share and per-share amounts reflect the July 28 share consolidation. Those details matter when comparing old share counts or earnings per share, even though they do not change the basic story about cannabis sales.

Flower and pre-rolls remain central

The management discussion says dried flower and pre-roll products accounted for approximately 64 percent of quarterly net revenue, with the balance from the company’s other cannabis product categories. It attributes year-over-year sales growth to higher volumes across core products and improved flower pricing, partly offset by pressure on vape prices.

That is more informative for readers following the cannabis shelf than an undifferentiated growth percentage. Different formats can move in different directions at the same company. Higher total revenue does not establish that every product category gained pricing power or that every retailer saw the same demand.

The filing also describes the role of Auxly Leamington in cultivation and processing. An integrated production footprint can support supply, but its existence alone does not demonstrate consumer preference, product quality or a future sales result. Those claims require evidence beyond the size of a facility.

The previous quarter supplies context

Auxly’s August 13 second-quarter announcement reported C$45.8 million in net revenue and C$14.3 million in adjusted EBITDA. The third-quarter figures are higher than those earlier results, as well as higher than the year-earlier revenue and adjusted EBITDA comparisons. That is a useful check on the direction of the reported business.

Quarter-to-quarter changes are still different from a sustained trend. Product launches, customer ordering and seasonal patterns can affect individual periods. A single quarter does not establish the eventual return on a capital project or the success of an export strategy.

Our earlier coverage of Weedmaps’ tougher advertising quarter illustrated another part of the cannabis economy. The companies have different business models and reporting measures, so their results should not be treated as interchangeable signals for the whole industry.

For Auxly, the next useful tests are continued demand, cash generation after working-capital movements and the results of planned investments. The present filing supports a specific conclusion: cannabis revenue and several operating indicators improved, while the reported net-income comparison requires attention to last year’s exceptional items.

Illustrative warehouse stock photograph; not an Auxly facility or identified cannabis inventory. Photo: Russ Murray / Unsplash.

Continue Reading

Cannabis

Charlotte’s Web Reports Lower CBD Sales but a Narrower Quarterly Operating Loss

The hemp-derived CBD company’s latest results show why lower revenue and an improving quarterly loss can coexist—and why neither resolves the policy outlook.

Published

on

Empty amber glass bottles arranged on a light surface

Charlotte’s Web reported a difficult sales quarter for its hemp-derived CBD business while narrowing its operating loss. Revenue for the three months ended September 30, 2026 was US$9.4 million, down 18.3 percent from a year earlier. Its operating loss narrowed to US$3.7 million from US$5.3 million, showing why the direction of sales and the direction of a loss do not always match.

The company announced the results November 12 and filed its quarterly report with the U.S. Securities and Exchange Commission. The release attributes weaker revenue primarily to California restrictions that took effect in July, reduced promotional discounting and softer demand in parts of the hemp-wellness market. Those explanations are management’s account of the quarter, rather than an independent measurement of every factor affecting CBD shoppers.

Less revenue does not automatically mean a larger loss

The company’s earnings release reports quarterly gross profit of about US$4.4 million, compared with US$4.5 million a year earlier, even as sales fell. Gross margin improved to 46.9 percent from 38.9 percent. Selling, general and administrative expenses declined to US$8.1 million from US$9.7 million.

A percentage margin and a dollar profit measure answer different questions. A company can retain a larger share of each sales dollar while bringing in fewer dollars overall. Lower expenses can then narrow the operating loss without putting the business into operating profit. That is the distinction these results require.

The announcement also identifies an inventory reserve linked to simplifying the product range. Readers should therefore resist interpreting a single margin percentage as a permanent new baseline. Product mix, pricing, manufacturing costs and inventory adjustments can all affect the calculation.

The quarterly filing keeps the periods straight

The Form 10-Q records quarterly revenue more precisely at US$9.393 million and a net loss of US$3.458 million. These rounded to the US$9.4 million revenue and US$3.5 million net loss in the announcement. An operating loss and a net loss are different lines of the accounts, not conflicting reports of one number.

The nine-month picture is also distinct from the latest quarter. The release reports a US$20.7 million net loss for the first nine months, including noncash items associated with the earlier debenture conversion. It would be misleading to describe an improved third-quarter operating loss as proof that every year-to-date earnings measure improved.

The filing shows US$11.364 million of cash and cash equivalents at September 30. Cash on that date is a financial-position measure, rather than sales or profit earned during the quarter. Looking at the income statement and cash-flow statement together gives a fuller picture than treating a positive cash balance as evidence of profitability.

Hemp policy remains part of the business story

Cannabis policy is directly relevant to this CBD company because the legal definition of hemp determines which products can use that route to market. The Congressional Research Service’s October 28 legal sidebar explains that the federal delay does not move every element of the new definition to the same date. It distinguishes the treatment of certain cannabinoids not naturally produced by the plant from provisions delayed until December 11.

That distinction is useful beyond one company. A hemp-derived label does not settle a product’s future legal status, and a federal deadline does not automatically override a state’s separate rules. Consumers and businesses need to identify the applicable product definition, ingredients and jurisdiction.

Charlotte’s Web’s October 28 announcement said it planned to hold a corporate update after December 11 rather than a November earnings call, seeking greater policy clarity before discussing its outlook. That is a communications plan, not evidence that Congress will produce the outcome the company prefers.

Product access and medical evidence are separate

A financial report from a CBD business does not establish that a product treats a disease or is appropriate for a particular person. Sales trends describe commercial activity. They do not measure a clinical benefit, and a discussion of future healthcare distribution should not be mistaken for a new drug approval or a general reimbursement entitlement.

Our coverage of Willie Nelson’s hemp-policy appeal addresses the public debate over access. Charlotte’s Web’s results supply a different perspective: how a company says restrictions, pricing decisions and expenses are affecting its accounts. The two stories illuminate different parts of the same policy uncertainty.

The next meaningful business signals will include the durability of any sales recovery, spending levels and the details of the legal framework actually in force. For now, the results show a smaller quarterly operating loss alongside lower CBD revenue. They do not yet resolve whether the company can turn that improvement into sustained growth and profitability.

Illustrative empty-bottle stock photograph; not Charlotte’s Web packaging or identified CBD products. Photo: Kelly Sikkema / Unsplash.

Continue Reading

Industry Innovators

Portland Weighs Cannabis Pickup Windows and Licensing Payment Changes

Portland’s cannabis pickup-window and licensing proposal remains under review, with the city record listing a December 8 committee meeting.

Published

on

Portland waterfront buildings seen across the river

Portland is considering removing a city-code restriction on cannabis drive-through and walk-up sales, but the proposal has not become a new retail permission. The city’s record for Ordinance 2026-407 shows the November 10 City Life Committee item was continued, with December 8 listed as its next meeting date.

The proposal introduced by Mayor Keith Wilson combines two subjects: updating the language governing exterior sales windows and revising the way licensing-payment provisions appear in city code. For cannabis shoppers, the first is about how a purchase might be collected. For operators, the second concerns the timing and administration of license costs.

A retailer considering a physical alteration would still need to assess the property and any other applicable approvals. Removing one cannabis-specific sales restriction is not the same thing as approving a building project.

The window restriction is specific

Portland’s current marijuana licensing chapter bars sales from vendor carts, temporary structures, satellite locations and exterior openings such as drive-through facilities or walk-up windows. The proposed amendment would remove the exterior-opening language while retaining restrictions on those other kinds of sales locations.

That is narrower than allowing cannabis sales anywhere a customer can drive or walk. A licensed premises would still be a particular business location, subject to the rest of its applicable requirements. The change concerns a method of serving customers, not the disappearance of the licensing system.

City materials say the amendment would align Portland’s wording with Oregon rules that made on-site delivery a permanent option in September 2020, following temporary pandemic arrangements. That history helps explain why the debate is framed as an update to conflicting language rather than a brand-new statewide retail model.

Convenience does not mean on-site consumption

One important boundary remains in the proposed code exhibit: the provision against consumption on licensed premises is retained, with its existing narrow employee exception under Oregon law. A pickup window and a consumption lounge are different activities.

The same exhibit retains operating-hour and security requirements. Its redline shows a targeted deletion concerning sales openings, rather than an across-the-board removal of the rules governing retail premises. Reading the actual proposed changes is more informative than assuming that the phrase drive-through implies a completely different type of store.

For a customer, the practical questions would still include whether a specific retailer offers a service, how the order is handled and which rules apply. A citywide code amendment, if adopted, would not guarantee that every shop installs a window or changes its property layout.

The payment provisions affect operators differently

The ordinance also addresses the Deferred Payment Program for license fees. The city’s explanation says a 50% initial payment better supports collection and that the code should refer to the council-approved fee schedule rather than preserve outdated dollar amounts.

That is a distinction between the text of the code and the administration of a program. City materials say programmatic changes were communicated in June and July and implementation began in August. The proposal would codify practices already in place, according to the city, rather than introduce every payment change for the first time.

Operators evaluating the proposal therefore need both the amended text and the applicable fee schedule. A headline about pickup windows does not explain a business’s entire licensing bill, and an old fixed amount quoted from code may not describe current program administration.

Businesses are raising questions about cash flow

In KPTV’s November 10 reporting, Mikhala Armstrong described support for greater accessibility alongside concerns from cannabis operators about payment obligations and late fees. Those interviews add an important perspective to the city’s stated goal of improving administration.

The two views are not interchangeable. The city describes its intended program effects; individual operators describe how they believe the arrangements affect their businesses. A final assessment should distinguish those accounts from evidence about what happens after implementation.

Our coverage of Missouri’s interstate cannabis guidance concerned a separate jurisdiction, but illustrates a related point: legal cannabis markets remain governed by specific rules at different levels. A state allowance does not make every local detail irrelevant.

The next step is still a public decision

The city’s document history is the place to follow whether the committee advances or amends the proposal. As of this review, its status is continued, not adopted. Readers should check the updated agenda before relying on the December meeting listing or making plans to offer a new service.

The potential change is concrete: remove a particular restriction on how licensed cannabis stores serve customers and bring fee language into line with current administration. Whether that becomes the final city policy remains the question before Portland, rather than a decision already made.

Illustrative Portland waterfront photograph; not a dispensary or proposed pickup site. Photo: Meggyn Pomerleau / Unsplash.

Continue Reading

Trending

Join The Cannabis Aficionado Community!
Join the Cannabis Aficionado community and receive all of the most relevant news geared towards our sophisticated enthusiast community.
Loading

Copyright ©️ 2026 Cannabis Aficionado. Cannabis Aficionado is a registered trademark of CNM Inc. All rights reserved. Registration on or use of this site constitutes acceptance of our Terms of Service, Privacy Policy and Cookies Policy. People may receive compensation for some links to products and services. Offers may be subject to change without notice.